U.S. Medical Equipment Stock News

Rollins (ROL) is back in focus after announcing that Executive Vice President and Chief Financial Officer Kenneth D. Krause will step down in mid June, with William W. Harkins set to take over. See our latest analysis for Rollins. Despite the CFO transition headlines, Rollins' share price has been under pressure recently. The stock is down 18.84% over 90 days and the 1 year total shareholder return is 12.10% lower, although the 5 year total shareholder return is 59.36%. If this kind of...

If you are wondering whether Exxon Mobil's recent share price leaves real value on the table or not, the key is to separate headline moves from what the underlying numbers suggest. The stock recently closed at US$146.96, after a share price that is up 19.8% year to date and 47.7% over the past 12 months, even though it has fallen 5.4% over the last week and 2.4% over the past month. These moves have come as Exxon Mobil continues to attract attention around its scale in global energy supply...

Primoris Services (PRIM) is back on investors’ radar after a sharp single day drop of about 3%. This is prompting a closer look at how its recent returns and fundamentals line up for infrastructure focused portfolios. See our latest analysis for Primoris Services. That 3% single day drop comes after a sharp 7 day share price return of 15.1%, set against a 30 day share price return that declined 25.1% and a year to date share price return that is down 3.1%, while the 1 year total shareholder...

Why Twenty One Capital is on investors’ radar Twenty One Capital (XXI) has drawn attention after a challenging year for the stock, with the share price down 82.6% over the past 12 months despite a market value of about US$2.5b. See our latest analysis for Twenty One Capital. At the current share price of US$7.33, the stock has seen a 90 day share price return of 27.7%, which only partially offsets the 1 year total shareholder return decline of 82.6%. This suggests that recent momentum is...

NuScale Power, NYSE:SMR, is highlighting its two separate U.S. Nuclear Regulatory Commission approvals as a key advantage for serving fast growing power needs from AI data centers and industrial users. The company is advancing commercial discussions that link its small modular reactor designs to long term electricity demand tied to AI infrastructure. This angle positions NuScale within the projected $10 trillion nuclear infrastructure opportunity connected to data center growth, an area...

Jack Henry & Associates (NasdaqGS:JKHY) secured its largest core platform contract to date with Woodforest National Bank. The agreement expands the company’s reach into larger financial institutions using its modern, integrated, cloud native solutions. Jack Henry & Associates focuses on technology and services that support banks and credit unions, including core processing, payments, and digital banking tools. For investors watching the fintech sector, a contract of this size highlights...

Arch Capital Group stock under pressure Arch Capital Group (ACGL) has been under consistent pressure recently, with the stock down about 6% over the past month and roughly 9% over the past 3 months, prompting investors to reassess the insurer. See our latest analysis for Arch Capital Group. That recent slide adds to a softer trend, with the share price return down 3.4% year to date and the 1 year total shareholder return down 3.75%. However, the 3 and 5 year total shareholder returns of...

Sandisk (NasdaqGS:SNDK) plans to launch its QLC Stargate platform for AI data center storage, with revenue-generating shipments targeted for Q4 FY2026. The QLC Stargate platform is designed to serve high-capacity AI workloads alongside Sandisk's existing TLC SSD products. The announcement focuses on AI-focused infrastructure rather than short-term stock or ETF flows. For investors watching Sandisk, the QLC Stargate announcement adds a fresh angle to a stock that has already seen sharp moves...

Earlier this year, Moelis & Company reported first-quarter revenue that matched analyst expectations but delivered earnings per share that fell well short of forecasts, highlighting higher-than-anticipated costs or margin pressure. This earnings miss came during a mixed quarter for independent advisers, where some peers exceeded both revenue and profit expectations, sharpening comparisons around Moelis’ efficiency and profitability. We’ll now explore how Moelis’ earnings shortfall, despite...

SentinelOne stock snapshot after recent performance shifts SentinelOne (S) has drawn fresh attention after a recent stretch of mixed returns, with the stock roughly flat over the past week, modestly higher over the past year, and showing stronger moves over the past month and the past 3 months. See our latest analysis for SentinelOne. At a share price of $18.02, SentinelOne’s recent 30-day share price return of 23.0% and 90-day share price return of 37.35% contrast with a more muted 1-year...

Mondelez International (MDLZ) is back on investor radar after recent share price gains, with the stock up about 6.6% over the past month and 1.3% over the past 3 months. See our latest analysis for Mondelez International. That recent momentum sits against a mixed longer record, with a 16.3% year to date share price return but a 1 year total shareholder return that is down 4.5%. This hints at shifting sentiment around Mondelez International’s growth and risk profile. If you are weighing...

Western Digital stock moves after recent performance surge Western Digital (WDC) has drawn fresh attention after a sharp share price move, with the stock showing double digit gains over the past month and the past 3 months, and a reported value score of 4. See our latest analysis for Western Digital. That recent surge fits into a much bigger move, with strong momentum in the share price over both the past quarter and year to date, alongside a very large 1 year total shareholder return and...

Merck (NYSE:MRK) received FDA Breakthrough Therapy designation for calderasib (MK-1084) in combination with KEYTRUDA. The designation covers first-line treatment of advanced or metastatic NSCLC with KRAS G12C mutation and PD-L1 expression. This is the first Breakthrough Therapy designation for calderasib, aimed at expediting development and regulatory review. For investors tracking NYSE:MRK, this update is closely tied to the company’s oncology franchise, centered on KEYTRUDA and related...

Hut 8 CEO Asher Genoot publicly addressed community concerns about the Beacon Point AI data center campus, focusing on environmental and local impact. Genoot highlighted closed-loop cooling systems designed to reduce water use, along with planned community investments tied to the project. The CEO also outlined the financing structure for Beacon Point, describing it as a multibillion dollar flagship infrastructure project for Hut 8. For investors watching NasdaqGS:HUT, this update adds...

Constellation Brands recently elected Morgan Flatley, McDonald’s Global Chief Marketing Officer and New Business Ventures lead, to its Board of Directors as an independent member, bringing extensive consumer-brand and marketing experience from McDonald’s and PepsiCo. This appointment continues the company’s board refresh and adds a marketer with a track record of high-impact global campaigns across food and beverage categories. Now we’ll examine how renewed analyst focus ahead of Q1 2027,...

LexinFintech Holdings’ previously scheduled Q1 2026 earnings release and earnings call, held on May 25, 2026, have drawn fresh attention to the company’s latest operating performance and management commentary. Alongside completing a US$39 million buyback of 9,600,000 shares announced in July 2025, the earnings-focused news flow has renewed interest in LexinFintech’s capital return story and business outlook. Against this backdrop, we’ll examine how the Q1 2026 earnings call and completed...

Marriott International (MAR) is trading in a travel sector that has recently benefited from falling crude oil prices and stronger vacation intentions, factors that help reduce cost pressure and support sentiment toward hotel operators. See our latest analysis for Marriott International. Alongside fresh expansion moves in India and an upcoming all inclusive resort project in Mexico, Marriott’s recent share price momentum looks strong, with a 30 day share price return of 7.66% and a 1 year...

PepsiCo Foundation, linked to NasdaqGS:PEP, has launched the Future Harvest program with EIT Food. The initiative targets around 900 young farmers across key European countries. The program is designed to support the next generation of farmers and address Europe's aging agricultural sector. For investors watching NasdaqGS:PEP, Future Harvest connects PepsiCo's core role in food and beverages with the realities of European agriculture. The company depends on long term access to crops such as...

Kimco Realty (KIM) is in focus after tenant Drip Coffee filed a lawsuit accusing the company of systemic fraud tied to alleged lease misrepresentation at a Florida shopping center redevelopment project. See our latest analysis for Kimco Realty. The lawsuit lands at a time when Kimco Realty’s share price has risen 20.49% year to date to US$24.17, while its 1 year total shareholder return of 18.67% and 3 year total shareholder return of 53.40% point to momentum that could be sensitive to any...

Zimmer Biomet’s recent share performance Zimmer Biomet Holdings (ZBH) has drawn investor attention after a mixed stretch, with the stock edging up about 0.3% over the past day but declining around 2.9% over the past week. See our latest analysis for Zimmer Biomet Holdings. At a share price of US$82.82, Zimmer Biomet’s short term share price momentum has softened, with the 90 day share price return down 15.87%, and the 5 year total shareholder return down 44.33%. This points to fading...

In recent days, Microchip Technology introduced its dsPIC33CK Value Line Digital Signal Controllers for cost-sensitive real-time control and launched 3.3 kV HV-D3 mSiC power modules aimed at AI data centers and high-voltage applications. Coupled with improving quarterly results and stronger bookings, these targeted launches highlight how Microchip is aligning its portfolio with AI, data center, automotive and industrial demand trends. We’ll now examine how Microchip’s new dsPIC33CK Value...

In May 2026, Associated Banc-Corp moved to expand its commercial banking capabilities in Texas by building a dedicated Corporate and Commercial Banking team in Dallas, doubling its Preston Center office space, and hiring veteran banker Brandon White as senior vice president and Dallas market leader. This push extends the bank’s branch-light commercial model that it previously applied in Kansas City, aiming to deepen relationship-based lending and treasury services across fast-growing...

In late May 2026, MannKind Corporation disclosed that the FDA has released it from a large, long-planned postmarketing lung cancer risk trial for Afrezza, leaving only a pediatric efficacy and safety requirement, while multiple new Afrezza and FUROSCIX data sets were presented at the American Diabetes Association’s 2026 Scientific Sessions. This shift meaningfully reduces Afrezza’s regulatory burden just as MannKind is pushing into pediatric use, including an ongoing INHALE-1st study in...

Nebius Group recently disclosed that AI-focused hedge fund Situational Awareness LP, led by former OpenAI researcher Leopold Aschenbrenner, has taken a passive 5.6% stake worth about US$2.60 billion, reinforcing confidence in Nebius’s role as an AI infrastructure provider. This investment, paired with Nebius’s very large year-over-year revenue growth, multi‑billion‑dollar GPU and compute agreements with partners such as Meta and Nvidia, and expansion into gigawatt‑scale AI campuses in the...